D. Allan Butterfield, PhD, Duke University 1974

Affiliations: 
Chemistry University of Kentucky, Lexington, KY 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=41
Website:
http://www.chem.uky.edu/research/butterfield/
Google:
"David Allan Butterfield"
Bio:

http://www.linkedin.com/profile/view?id=72026846&authType=NAME_SEARCH&authToken=pLTP&locale=en_US&srchid=22bebd9a-7b21-4563-8839-3518100646a6-0&srchindex=1&srchtotal=6&pvs=p
https://chem.as.uky.edu/sites/default/files/cv/Vitae_with_Supplemental_Vitae%20%2010-11-17.pdf

Cross-listing: Chemistry Tree

Parents

Sign in to add mentor
Donald B. Chesnut grad student 1974 Duke (Chemistry Tree)
 (Spin Label Investigations of Model and Biological Membranes: I. Radical Decay Kinetics in an Electron Transport Enzyme System II. Studies on Erythrocytes From Patients With Myotonic Muscular Dystrophy.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Perluigi M, Tramutola A, Pagnotta S, et al. (2020) The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia. Antioxidants (Basel, Switzerland). 9
Di Domenico F, Tramutola A, Barone E, et al. (2019) Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome. Redox Biology. 101162
Salameh TS, Mortell WG, Logsdon AF, et al. (2019) Disruption of the hippocampal and hypothalamic blood-brain barrier in a diet-induced obese model of type II diabetes: prevention and treatment by the mitochondrial carbonic anhydrase inhibitor, topiramate. Fluids and Barriers of the Cns. 16: 1
Tramutola A, Lanzillotta C, Barone E, et al. (2018) Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome. Translational Neurodegeneration. 7: 28
Butterfield DA, Boyd-Kimball D. (2018) Redox Proteomics and Amyloid β-Peptide: Insights into Alzheimer Disease. Journal of Neurochemistry
Keeney JTR, Ren X, Warrier G, et al. (2018) Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment ("chemobrain"). Oncotarget. 9: 30324-30339
Barone E, Tramutola A, Triani F, et al. (2018) Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease. Molecular Neurobiology
Tramutola A, Sharma N, Barone E, et al. (2018) Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease. Biochimica Et Biophysica Acta
Butterfield DA, Boyd-Kimball D. (2018) Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 62: 1345-1367
Butterfield DA, Perluigi M. (2017) Down Syndrome: From Development to Adult Life to Alzheimer Disease. Free Radical Biology & Medicine
See more...